AIM: To investigate the value of staging laparoscopy with laparoscopic ultrasound (LUS) and peritoneal lavage cytology in patients with newly-diagnosed gastric tumours in our department. METHODS: Retrospective review of prospectively-collected data was conducted in all patients with newly-diagnosed gastric tumours on oesophagogastroduodenoscopy between December 2003 and July 2008. All the patients had a pre-treatment histological diagnosis and were discussed at the hospital multidisciplinary tumour board meeting for their definitive management. Computed tomography scan was performed in all patients as a part of standard preoperative staging work up. Staging laparoscopy was subsequently performed in selected patients and staging by both modalities was compared. RESULTS: Twenty seven patients were included. Majority of patients had cardio-oesophageal junction adenocarcinoma. Thirteen patients (48%) were upstaged following staging laparoscopy and one patient was downstaged (3.7%). None of the patients had procedure-related complications. None of the patients with metastasis detected at laparoscopy underwent laparotomy. Gastrectomy after staging laparoscopy was performed in 13 patients (9 R0 resections, 3 R1 resections and 1 R2 resection). Only one patient did not have gastrectomy at laparotomy because of extensive local invasion. Three patients were subjected to neoadjuvant therapy following laparoscopy but only one patient subsequently underwent gastrectomy. CONCLUSION: In this small series reflecting our institutional experience, staging laparoscopy appears to be safe and more accurate in detecting peritoneal and omental metastases as compared to conventional imaging. Peritoneal cytology provided additional prognostic information although there appeared to be a high false negative rate.
AIM: To investigate the value of staging laparoscopy with laparoscopic ultrasound (LUS) and peritoneal lavage cytology in patients with newly-diagnosed gastric tumours in our department. METHODS: Retrospective review of prospectively-collected data was conducted in all patients with newly-diagnosed gastric tumours on oesophagogastroduodenoscopy between December 2003 and July 2008. All the patients had a pre-treatment histological diagnosis and were discussed at the hospital multidisciplinary tumour board meeting for their definitive management. Computed tomography scan was performed in all patients as a part of standard preoperative staging work up. Staging laparoscopy was subsequently performed in selected patients and staging by both modalities was compared. RESULTS: Twenty seven patients were included. Majority of patients had cardio-oesophageal junction adenocarcinoma. Thirteen patients (48%) were upstaged following staging laparoscopy and one patient was downstaged (3.7%). None of the patients had procedure-related complications. None of the patients with metastasis detected at laparoscopy underwent laparotomy. Gastrectomy after staging laparoscopy was performed in 13 patients (9 R0 resections, 3 R1 resections and 1 R2 resection). Only one patient did not have gastrectomy at laparotomy because of extensive local invasion. Three patients were subjected to neoadjuvant therapy following laparoscopy but only one patient subsequently underwent gastrectomy. CONCLUSION: In this small series reflecting our institutional experience, staging laparoscopy appears to be safe and more accurate in detecting peritoneal and omental metastases as compared to conventional imaging. Peritoneal cytology provided additional prognostic information although there appeared to be a high false negative rate.
Authors: L F Oñate-Ocaña; D Gallardo-Rincón; V Aiello-Crocifoglio; R Mondragón-Sánchez; J de-la-Garza-Salazar Journal: Ann Surg Oncol Date: 2001-09 Impact factor: 5.344
Authors: E J Nieveen van Dijkum; L T de Wit; O M van Delden; E A Rauws; J J van Lanschot; H Obertop; D J Gouma Journal: Cancer Date: 1997-04-01 Impact factor: 6.860
Authors: H J F Brenkman; E C Gertsen; E Vegt; R van Hillegersberg; M I van Berge Henegouwen; S S Gisbertz; M D P Luyer; G A P Nieuwenhuijzen; J J B van Lanschot; S M Lagarde; W O de Steur; H H Hartgrink; J H M B Stoot; K W E Hulsewe; E J Spillenaar Bilgen; M J van Det; E A Kouwenhoven; D L van der Peet; F Daams; J W van Sandick; N C T van Grieken; J Heisterkamp; B van Etten; J W Haveman; J P Pierie; F Jonker; A Y Thijssen; E J T Belt; P van Duijvendijk; E Wassenaar; H W M van Laarhoven; F J Wessels; N Haj Mohammad; H F van Stel; G W J Frederix; P D Siersema; J P Ruurda Journal: BMC Cancer Date: 2018-04-20 Impact factor: 4.430